DreamCIS' (KOSDAQ:223250) Performance Is Even Better Than Its Earnings Suggest
May 24
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Clinical Research and Equipment Industry Analysis
UpdatedMay 31, 2025
DataAggregated Company Financials
Companies29
- 7D1.9%
- 3M-2.8%
- 1Y48.3%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has risen 1.9%, driven by gains from Samsung BiologicsLtd of 1.6%. In the same time, ORIENT BIO was down 13%. This means that the industry has gained 48% over the past year. Earnings are forecast to grow by 16% annually.
Industry Valuation and Performance
Has the South Korean Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 01 Jun 2025 | ₩85.4t | ₩5.6t | ₩1.2t | 15.4x | 69.3x | 15.2x |
| Tue, 29 Apr 2025 | ₩84.0t | ₩5.2t | ₩1.0t | 17.8x | 81.9x | 16.1x |
| Thu, 27 Mar 2025 | ₩84.5t | ₩5.2t | ₩1.0t | 10.2x | 83.8x | 16.2x |
| Sat, 22 Feb 2025 | ₩91.2t | ₩5.0t | ₩965.6b | 13x | 94.4x | 18.2x |
| Mon, 20 Jan 2025 | ₩81.3t | ₩5.0t | ₩965.6b | 13.1x | 84.2x | 16.2x |
| Wed, 18 Dec 2024 | ₩77.6t | ₩4.7t | ₩993.5b | 15.5x | 78.1x | 16.3x |
| Fri, 15 Nov 2024 | ₩77.0t | ₩4.8t | ₩885.3b | 12.4x | 87x | 15.9x |
| Sun, 13 Oct 2024 | ₩81.7t | ₩4.8t | ₩885.3b | 14x | 92.3x | 16.8x |
| Tue, 10 Sep 2024 | ₩75.4t | ₩4.8t | ₩885.3b | 14.3x | 85.1x | 15.5x |
| Thu, 08 Aug 2024 | ₩75.2t | ₩4.5t | ₩731.7b | 15.4x | 102.7x | 16.6x |
| Sat, 06 Jul 2024 | ₩63.8t | ₩4.5t | ₩731.7b | 18.6x | 87.2x | 14.1x |
| Mon, 03 Jun 2024 | ₩57.6t | ₩4.6t | ₩695.2b | 20.4x | 82.8x | 12.4x |
| Wed, 01 May 2024 | ₩63.1t | ₩4.7t | ₩654.7b | 19.2x | 96.4x | 13.5x |
| Fri, 29 Mar 2024 | ₩66.4t | ₩4.7t | ₩644.3b | 19.4x | 103x | 14.2x |
| Sun, 25 Feb 2024 | ₩63.9t | ₩4.5t | ₩714.4b | 34.9x | 89.4x | 14.1x |
| Tue, 23 Jan 2024 | ₩62.2t | ₩4.5t | ₩714.4b | 33.8x | 87x | 13.7x |
| Thu, 21 Dec 2023 | ₩56.8t | ₩4.5t | ₩721.5b | 31.3x | 78.7x | 12.5x |
| Sat, 18 Nov 2023 | ₩56.9t | ₩4.4t | ₩649.3b | 23.5x | 87.6x | 12.9x |
| Mon, 16 Oct 2023 | ₩57.0t | ₩4.4t | ₩660.9b | 37.5x | 86.2x | 13x |
| Wed, 13 Sep 2023 | ₩57.8t | ₩4.4t | ₩659.1b | 28.4x | 87.7x | 13.1x |
| Fri, 11 Aug 2023 | ₩63.0t | ₩4.2t | ₩673.4b | 29.5x | 93.6x | 15x |
| Sun, 09 Jul 2023 | ₩56.1t | ₩4.2t | ₩673.4b | 28.4x | 83.3x | 13.4x |
| Tue, 06 Jun 2023 | ₩61.2t | ₩4.2t | ₩666.5b | 32.3x | 91.8x | 14.4x |
| Thu, 04 May 2023 | ₩60.7t | ₩4.1t | ₩626.3b | 27.4x | 96.9x | 14.8x |
| Sat, 01 Apr 2023 | ₩61.2t | ₩4.1t | ₩626.3b | 28.5x | 97.8x | 15x |
| Mon, 27 Feb 2023 | ₩61.1t | ₩3.5t | ₩427.8b | 20.7x | 142.9x | 17.5x |
| Wed, 25 Jan 2023 | ₩62.4t | ₩3.5t | ₩426.6b | 19.7x | 146.2x | 17.9x |
| Fri, 23 Dec 2022 | ₩64.4t | ₩3.4t | ₩428.7b | 22x | 150.1x | 18.7x |
| Sun, 20 Nov 2022 | ₩68.6t | ₩3.4t | ₩440.9b | 24.7x | 155.6x | 20.2x |
| Tue, 18 Oct 2022 | ₩62.7t | ₩3.0t | ₩448.5b | 22.2x | 139.7x | 21x |
| Thu, 15 Sep 2022 | ₩65.0t | ₩3.0t | ₩448.5b | 29x | 145x | 21.8x |
| Sat, 13 Aug 2022 | ₩71.9t | ₩2.7t | ₩454.7b | 28.3x | 158.2x | 26.5x |
| Mon, 11 Jul 2022 | ₩65.0t | ₩2.7t | ₩454.7b | 28.8x | 143x | 23.9x |
| Wed, 08 Jun 2022 | ₩66.2t | ₩2.7t | ₩454.1b | 27x | 145.8x | 24.5x |
Price to Earnings Ratio
145.8x
Current Industry PE
- Investors are pessimistic on the South Korean Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 69.3x which is lower than its 3-year average PE of 103x.
- The industry is trading close to its 3-year average PS ratio of 16.4x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have grown 39% per year over the last three years.
- Revenues for these companies have grown 28% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does South Korean Clinical Research and Equipment compare with similar industries?
| KR Market | 3.91% | |
| Healthcare | 2.96% | |
| Life Sciences | 1.93% | |
| Clinical Research and Equipment | 1.93% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A207940 Samsung BiologicsLtd | ₩1.03m | 1.6% +₩1.1t | 41.4% | PE57.4x | |
| A087010 Peptron | ₩232.50k | 5.7% +₩291.2b | 530.1% | PS1261.1x | |
| A141080 LigaChem Biosciences | ₩114.90k | 4.1% +₩163.3b | 80.4% | PE167.7x | |
| A114450 Green Lifescience | ₩3.96k | 38.2% +₩21.4b | 97.0% | PS3.3x | |
| A220100 FutureChemLtd | ₩17.29k | 2.1% +₩7.7b | 6.9% | PS20.2x |
